title: SNCA, LRRK2, MAPT polymorphisms and Parkinson's disease in Russia.
authors.affiliation: Petersburg Nuclear Physics Institute, St. Petersburg, Russia; Pavlov's State Medical University of Saint-Petersburg, St. Petersburg, Russia; St. Petersburg Academic University - Nanotechnology Research and Education Centre, RAS, St. Petersburg, Russia.
authors.forename: A
authors.initials: A
authors.lastname: Emelyanov
authors.forename: P
authors.initials: P
authors.lastname: Andoskin
authors.forename: A
authors.initials: A
authors.lastname: Yakimovskii
authors.forename: T
authors.initials: T
authors.lastname: Usenko
authors.forename: E
authors.initials: E
authors.lastname: Nuzhnyi
authors.forename: M
authors.initials: M
authors.lastname: Nikolaev
authors.forename: S
authors.initials: S
authors.lastname: Pchelina
mesh_terms: D044466:Asian People / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D051844:alpha-Synuclein / Q000235:genetics*
chemical_list: D051844:alpha-Synuclein
keywords: Genetic association; LRRK2; MAPT; Parkinson's disease; Risk factor; SNCA